Occupational blood exposure accidents (OBEAs) pose significant risks to healthcare workers, potentially exposing them to hepatitis B (HBV), hepatitis C (HCV), and HIV. While most research focuses on hospital settings, this study assessed OBEA management in non-hospital contexts. Although our data predate the COVID pandemic, findings remain highly relevant, especially for healthcare professionals working outside hospital settings. A retrospective analysis of OBEA registry data (2006–2014) was conducted in a southern Dutch region. Data included demographics, profession, workplace, injury type, source status (HBV, HCV, HIV), risk assessment, post-exposure measures, and lab results. Chi-square and t-tests were applied. In total, 975 OBEA were reported. Among nurses, medical assistants, students, and housekeeping staff, subcutaneous needles (51–67%) and lancets (25%) were common exposure sources. Police officers mainly reported biting (26%), scratching, or spitting (70%). HBV vaccination coverage ranged from 18% (housekeeping) to over 90% (nurses, police). Post-exposure measures were taken in 52% of cases. High-risk exposures (43%) mainly affected ambulance staff, sterilization workers, police, and dentists. Sources were tested in 85% of high-risk cases: 1.4% were HBV positive, 2% HCV positive, and 1.1% HIV positive. No seroconversions occurred. Results stress the need for better HBV vaccination coverage, targeted prevention, and prompt OBEA reporting outside hospital settings.

This retrospective, cross-sectional study assessed the burden of HIV in Israel’s Maccabi Healthcare Services in 2022. Among 2.6 million individuals assessed (lookback period: > 2 decades), 1973 PWH were identified and age-sex-matched (1:5) to 9,865 randomly selected controls without HIV. We compared sociodemographic, clinical characteristics, and healthcare resource utilization (HRU; Jan–Dec 2022) between people with and without HIV and characterized antiretroviral therapy (ART) treatment patterns among PWH (Jan–Dec 2022). Compared to controls, PWH had a higher lifetime prevalence (since 1988; P < 0.001) of several comorbid conditions, including liver disease, chronic kidney disease, any cancer, and hepatitis B and C infections. Additionally, PWH had a higher rate of anxiety and depression (26.2% vs. 13.5%; P < 0.001). PWH showed higher annual HRU than controls, including ~2-fold higher hospitalizations (≥1 new admissions; P < 0.001) and frequent use of emergency, urgent, primary, specialist, and nursing care (P < 0.05). Among 1907 PWH with ≥1 ART prescription, 78.1% had ≥90% coverage in 2022, although 69.1% experienced ART interruption and 7.2% discontinuation, the latter associated with mental health issues. This study recognizes critical gaps in care that could inform strategies to improve clinical outcomes and resource allocation in health systems for PWH.

We conducted an exploratory cross-sectional analysis of ethical principles and practices in forty-one published research papers with empirical data on HIV prevalence, incidence, or risk factors in humanitarian settings. We identified ten key concepts pertinent to ethical principles and applications, and presented recommendations to inform future HIV prevention research.

Sexually transmitted infections (STIs) are common among people living with human immunodeficiency virus (HIV) (PLWH). This nationwide register study linked HIV and STI registries to examine STI trends before and after HIV diagnosis in Finland 1995–2019 among all PLWH residing in the country. Analysed STIs were chlamydia, gonorrhoea, syphilis, and hepatitis B and C. An extended Cox model assessed factors associated with STI events. Among 3,775 PLWH (mean follow-up 17.9 person-years), 71% had no STIs, 17% had one, and 12% had two or more. Overall, 10.7% had an STI before HIV diagnosis and 18.1% after. STI incidence was 32 per 1,000 person-years and increased over time, although chlamydia and gonorrhoea declined. STI risk was highest among men who have sex with men (MSM) and lowest among people who inject drugs; it remained stable or declined after HIV diagnosis. STIs before HIV diagnosis offer opportunities for HIV testing and pre-exposure prophylaxis promotion. As most had no STIs other than HIV, HIV testing should not be limited to STI screening but also performed in other indicator conditions. After HIV diagnosis, accessible low-threshold STI testing, particularly for MSM, and consideration of doxycycline prophylaxis may benefit those at highest risk.

This paper examines the potential for, and the contradictions inherent in, voluntary sector health service providers acting as consumer representatives. The paper examines a U.K. gay men’s HIV prevention organization to consider whether members are united by their experiences of using services, whether their work involves consumerist strategies, if so whether these are influential, and what tensions emerge from the dual provider/consumer role. Fieldwork was carried out in 1997-98, examining, via documents and interviews, activity between 1992 and 1997. Qualitative analysis was performed. Consumer action is shown to emerge not so much from abstract constructions of consumer interest, but more from the particularities of consumption, which become politicized more powerfully through their attachment to other interests and ideologies.

HIV civil society advocacy in Vietnam is shaped by a unique fusion of historic and contemporary influences, resulting in nuanced ways in which advocacy is practised. In this study, we interviewed representatives from civil society, the Government of Vietnam, international NGOs, multilateral and research organisations and commercial consultancies to identify the influences on advocacy practice today. Aspects of Confucianism, Buddhism, Communism and changes to international funding were all identified as shaping HIV civil society policy advocacy practice directed towards government. These influences have resulted in a strong respect for hierarchy, non-confrontational and collaborative working relationships between civil society and the government, decision-making by consensus and changes in advocacy practice corresponding to fluctuations in international funding. This study shows how, as civil society continues to develop its role in the HIV sector in Vietnam, it is critical to understand these complex influences so that program designers, funders and evaluators can appropriately support HIV civil society policy advocacy.

This commentary discusses research workforce programs designed to enhance the representation and engagement of Latinos in HIV research, highlighting key challenges and proposing actionable strategies for improvement. Mentorship education and cultural inclusivity are identified as the most salient issues because the former leads to stronger health-related outcomes and is linked to cognitive-and career-related factors while the latter offers the potential to directly dismantle structures of inequity. This commentary suggests recasting of Diversity, Equity, and Inclusion (DEI) initiatives from eligibility as Latino self-identification, to all individuals’ lived experiences and/or prior experience in service/research activities. Some issues and constructs (i.e., heterogeneity, perseverance, acculturation, cultural values), typically important for certain underrepresented minoritized groups in diversity workforce programs, are reinterpreted for their relevance to all potential participants. This commentary proposes a holistic approach to trainee eligibility, creating a more inclusive environment that respects both individuality and diversity, and, importantly, contributing to DEI does not require being a member of an underrepresented minoritized population group.

Female genital schistosomiasis (FGS) remains a neglected sexual and reproductive health (SRH) condition, predominantly affecting women and girls in sub‐Saharan Africa. Infection with Schistosoma haematobium, resulting in trapped parasite eggs in the genital tract, causes lesions that mimic sexually transmitted infections and cervical neoplasia, often leading to misdiagnosis, stigma and delayed treatment. This review summarises current developments on FGS burden, prevention, diagnostics, integration, policy, community engagement and identifies critical threats to progress. Ongoing surveys show promise in ensuring robust burden estimates and age‐related risk data. Diagnostic advances include portable colposcopy, digital image analysis techniques and molecular assays, although limitations persist in resource‐limited settings. Praziquantel remains the cornerstone of treatment, yet single‐dose regimens inadequately reverse established lesions; repeated dosing shows improved parasite clearance but limited lesion regression, highlighting the necessity for early, life‐course preventive chemotherapy including access to paediatric praziquantel. Successful programmatic pilots have developed training curricula, minimum service packages, community engagement tools and have integrated FGS care into SRH platforms. Policy momentum is building through World Health Organization taskforces and national strategies, yet sustainable financing remains a challenge. Key threats include bilateral aid reductions, climate change, emerging infections, rising healthcare costs and persistent gender inequities. To address these challenges, we propose seven priority actions, encompassing all health system building blocks, for the global community. Nationally coordinated, multisectoral efforts are urgently required to embed FGS prevention, diagnosis and management within broader health systems, thereby improving outcomes for affected women and girls.

Dioecious species that reproduce by internal fertilization typically carry an associated risk of exposure to sexually transmitted parasites and pathogens. When hosts intermingle for procreation, certain protist and helminth parasites, for example, transfer successfully between individuals and then navigate across various life history traits of their hosts, often probing dimensions in both sex and gender, respectively. In humans, there are many sexually transmitted infections as well as sexually transmitted diseases. A well-known sexually transmitted infection is the flagellated protist Trichomonas vaginalis that causes trichomoniasis, with over 150 million new cases reported annually. By contrast, the schistosome blood fluke Schistosoma haematobium, though not a sexually transmitted infection, causes significant damage to the male and female genital tracts. Such overt damage raises risks of spreading and acquiring Human Immunodeficiency Virus and Human Papilloma Virus. In Africa, over 50 million women continue to suffer from female genital schistosomiasis, alongside a poorly quantified global burden of travel-related infections. In conjunction with male genital schistosomiasis, urogenital schistosomiasis causes much suffering, within and between afflicted households, inclusive of stigmatization. Both trichomoniasis and schistosomiasis expose several public health needs currently addressed inadequately by routine sexual and reproductive health services. This preface to the Parasitology Special Issue entitled ‘Parasites of the genital tract: short- and long-term consequences’, introduces 19 papers that explore the short – and long-term impacts of parasitic infections within the genital tract. While current parasitological research is weighted towards human medicine, we encourage future studies that explore veterinary contexts and analogous parasitic diseases within wildlife.

Due to the widespread availability of effective antiretroviral therapy regimens, average lifespans of persons with HIV (PWH) in the United States have increased significantly in recent decades. In turn, the demographic profile of PWH has shifted. Older persons comprise an ever-increasing percentage of PWH, with this percentage expected to further increase in the coming years. This has profound implications for HIV treatment and care, as significant resources are required not only to manage HIV itself, but also associated age-related comorbidities and health conditions that occur in ageing PWH. Effective management of these challenges in the coming years requires accurate modelling of the PWH age structure. In the present work, we introduce several novel mathematical approaches related to this problem. We present a workflow combining a PDE model for the PWH population age structure, where publicly available HIV surveillance data are assimilated using the Ensemble Kalman Inversion algorithm. This procedure allows us to rigorously reconstruct the age-dependent mortality trends for PWH over the last several decades. To project future trends, we introduce and analyse a novel variant of the dynamic mode decomposition (DMD), nonnegative DMD. We show that nonnegative DMD provides physically consistent projections of mortality and HIV diagnosis while remaining purely data-driven, and not requiring additional assumptions. We then combine these elements to provide forecasts for future trends in PWDH mortality and demographic evolution in the coming years.

Human immunodeficiency virus (HIV) and mental health have complex, bidirectional impacts. Integrated service delivery, especially in low- and middle-income countries (LMICs) where resources are most limited and the burden of HIV is heaviest, may help to improve both HIV and mental health outcomes. While the integration of mental health and HIV services has been studied in various settings, previous reviews on this topic have primarily focused on the integration processes rather than health outcomes. In this systematic review, we evaluated the effectiveness of interventions in LMICs that integrated mental health and HIV services. We searched PubMed, CINAHL, Sociological Abstracts, PsycINFO and EMBASE and conducted backward and forward citation searches. We included studies conducted in LMICs that evaluated the integration of services for HIV and mental health conditions using pre-post or multi-arm study designs, published in a peer-reviewed journal from January 2000 through January 2024. Studies on substance use services were excluded. Risk of bias for included studies was assessed using the Evidence Project tool. We summarized findings narratively, including both mental health-related and HIV-related outcomes. Eighteen studies with a total of 9,729 participants were included in the analysis, among which 17 studies were conducted in sub-Saharan Africa and 10 were randomized controlled trials. Seventeen studies used a task-sharing approach, where nonspecialists provided mental health interventions. The low follow-up rate and lack of random participant selection suggested the increased risk of bias in most studies. Overall, interventions that integrated mental health and HIV services provided greater improvement in recipients’ mental health symptoms (e.g., depression and post-traumatic stress disorder) than HIV services alone, often reducing symptom scores by more than 50%. While the evidence on HIV-related outcomes (e.g., antiretroviral therapy adherence, viral suppression and HIV stigma) was more limited, most studies that reported these outcomes showed positive effects of integrated interventions, especially community-based ones. These findings suggest the benefit of the interventions that integrate mental health and HIV services in LMICs, although further evaluations are warranted.